| # | Drug | Count |
|---|---|---|
| 0 | ESOMEPRAZOLE | 2 |
| 1 | ESOMEPRAZOLE MAGNESIUM | 2 |
| 2 | OXAZEPAM | 2 |
| 3 | CAPECITABINE | 1 |
| 4 | CELECOXIB | 1 |
| 5 | CLONAZEPAM | 1 |
| 6 | DAPAGLIFLOZIN | 1 |
| 7 | EZETIMIBE | 1 |
| 8 | FAMOTIDINE | 1 |
| 9 | FUROSEMIDE | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SODIUM SULFATE, MAGNESIUM SULFATE, AND POTASSIUM CHLORIDE | 1 | 0.0006 |
| 1 | ICOSAPENT ETHYL | 1 | 0.0001 |
| 2 | OXAZEPAM | 2 | 0.0001 |
| 3 | DAPAGLIFLOZIN | 1 | 0.0000 |
| 4 | SITAGLIPTIN | 1 | 0.0000 |
| 5 | OXALIPLATIN | 1 | 0.0000 |
| 6 | EZETIMIBE | 1 | 0.0000 |
| 7 | CAPECITABINE | 1 | 0.0000 |
| 8 | TADALAFIL | 1 | 0.0000 |
| 9 | PEMBROLIZUMAB | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Dipeptidyl Peptidase 4 Inhibitor [EPC] | 1 | 0.0000 |
| 1 | Dietary Cholesterol Absorption Inhibitor [EPC] | 1 | 0.0000 |
| 2 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 1 | 0.0000 |
| 3 | Histamine-2 Receptor Antagonist [EPC] | 1 | 0.0000 |
| 4 | Phosphodiesterase 5 Inhibitor [EPC] | 1 | 0.0000 |
| 5 | Platinum-based Drug [EPC] | 1 | 0.0000 |
| 6 | Nucleoside Metabolic Inhibitor [EPC] | 1 | 0.0000 |
| 7 | Proton Pump Inhibitor [EPC] | 2 | 0.0000 |
| 8 | Benzodiazepine [EPC] | 2 | 0.0000 |
| 9 | Loop Diuretic [EPC] | 1 | 0.0000 |